Contents

Recent Patents on CNS Drug Discovery (Discontinued), Volume 2 - Number 1

Author Index To Volume 1

, 2(1): ii

Bentham Science Publisher


DOI: 10.2174/15748898107020100ii




Subject Index To Volume 1

, 2(1): vi

Bentham Science Publisher


DOI: 10.2174/15748898107020100vi




Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders

, 2(1): 1 - 21

Christa E. Muller and Sergi Ferre


DOI: 10.2174/157488907779561772




Novel Molecular Targets for the Prevention of Fetal Alcohol Syndrome

, 2(1): 23 - 35

Susana E. Martinez and Gustavo Egea


DOI: 10.2174/157488907779561763




Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation

, 2(1): 37 - 46

Rodrigo R. Resende, Henning Ulrich and Marcella Faria


DOI: 10.2174/157488907779561736




Glutamatergic Dysfunction-Newer Targets for Anti-Obsessional Drugs

, 2(1): 47 - 55

Sagnik Bhattacharyya and Koushik Chakraborty


DOI: 10.2174/157488907779561727




Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases

, 2(1): 57 - 78

Istvan Tarnawa, Hedvig Bolcskei and Pal Kocsis


DOI: 10.2174/157488907779561754




Implication of Possible Therapies Targeted for the Tachykinergic System with the Biology of Neurokinin Receptors and Emerging Related Proteins

, 2(1): 79 - 84

Pranela Rameshwar


DOI: 10.2174/157488907779561781




Patent Annotations

, 2(1): 85 - 89

Bentham Science Publisher


DOI: 10.2174/157488907779561817




Patent Selections

, 2(1): 91 - 98

Bentham Science Publisher


DOI: 10.2174/157488907779561790




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science